Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury

NCT02237547 is registered in ClinicalTrials.gov with Translational Biosciences as lead sponsor.

NCT NCT02237547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
Lead sponsor
Translational Biosciences
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 30, 2014
Completion date
October 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury